Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

21

Revenue 2017

41

Revenue 2017

Xarelto

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Xarelto was produced by Bayer and Johnson & Johnson.

J&J's share buyback 'doesn't prevent acquisitions'

J&J's share buyback 'doesn't prevent acquisitions' Novel oral anticoagulant (NOAC) Xarelto (rivaroxaban) climbed 11.4% to $461m while Imbruvica (ibrutinib) for B cell cancers gathered momentum with a threefold rise in sales to $184m and diabetes drug

NICE recommends Daiichi Sankyo's Lixiana for DVT and PE

NICE recommends Daiichi Sankyo's Lixiana for DVT and PE The DVT and PE guidance puts Lixiana, the fourth novel oral anticoagulant to reach the market, on par with Bayer's Xarelto (rivaroxaban), Boehringer Ingelheim's Pradaxa (dabigatran) and

Daiichi’s new anticoagulant recommended by NICE

Daiichi’s new anticoagulant recommended by NICE patients. These include Bayer/Janssen's Xarelto (rivaroxaban); Boehringer's Pradaxa (dabigatran); and Pfizer/BMS's Eliquis (apixaban).

Boehringer returns to growth in first half

Boehringer returns to growth in first half Bayer/Johnson &Johnson's Xarelto (rivaroxaban), as well as Daiichi Sankyo's new entrant Lixiana/Savaysa (edoxaban).

J&J starts to feel biosimilar competition bite

J&J starts to feel biosimilar competition bite J&J had plenty of positive news to report, however, including a 31% increase in sales of novel oral anticoagulant Xarelto (rivaroxaban) to $472m in the quarter and rapid-take up

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...